These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27320333)

  • 21. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.
    Fujii S; Ohsawa F; Yamada S; Shinozaki R; Fukai R; Makishima M; Enomoto S; Tai A; Kakuta H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5139-42. PubMed ID: 20656484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cells.
    Austin G; Holcroft A; Rinne N; Wang L; Clark RE
    Eur J Haematol; 2015 Jan; 94(1):74-8. PubMed ID: 25039279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid X receptor ligands: a patent review (2007 - 2013).
    Yamada S; Kakuta H
    Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses.
    Mengeling BJ; Furlow JD
    Toxicol In Vitro; 2015 Oct; 29(7):1609-18. PubMed ID: 26096596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex.
    Ziouzenkova O; Plutzky J
    FEBS Lett; 2008 Jan; 582(1):32-8. PubMed ID: 18068127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
    Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
    Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
    James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
    Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
    Jurutka PW; Wagner CE
    Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment.
    Fattori J; Campos JL; Doratioto TR; Assis LM; Vitorino MT; Polikarpov I; Xavier-Neto J; Figueira AC
    Mol Endocrinol; 2015 Feb; 29(2):258-73. PubMed ID: 25541638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.